Nanodecoys made from human lung spheroid cells (LSCs) can bind to and neutralize SARS-CoV-2, promoting viral clearance and reducing lung injury in a macaque model of COVID-19. By mimicking the receptor that the virus binds ...
Bio & Medicine
Jun 17, 2021
0
444
Bay Area scientists have captured the real-time electrical activity of a beating heart, using a sheet of graphene to record an optical image—almost like a video camera—of the faint electric fields generated by the rhythmic ...
Bio & Medicine
Jun 16, 2021
0
1030
Nanoengineers at the University of California San Diego have developed immune cell-mimicking nanoparticles that target inflammation in the lungs and deliver drugs directly where they're needed. As a proof of concept, the ...
Bio & Medicine
Jun 16, 2021
0
1306
Tested on human blood in the lab, the selective nanocapsules could reduce the side effects of a major blood clot dissolving drug, which include bleeding on the brain. If confirmed with animal tests, the nanocapsules could ...
Bio & Medicine
Jun 2, 2021
0
191
Drug carriers that target the vascular endothelium must adhere to the endothelial vessel wall to achieve clinical stability. The particle size is a critical physical property to prescribe particle margination within biological ...
In a new report now published on Science, Robby Divine and an interdisciplinary research team at the department of biochemistry, regenerative medicine, and vaccines and infectious disease at the University of Washington U.S. ...
Small-molecule therapeutics treat a wide variety of diseases, but their effectiveness is often diminished because of their pharmacokinetics—what the body does to a drug. After administration, the body dictates how much of ...
Bio & Medicine
Mar 31, 2021
0
132
Using an ordinary light microscope, MIT engineers have devised a technique for imaging biological samples with accuracy at the scale of 10 nanometers—which should enable them to image viruses and potentially even single biomolecules, ...
Bio & Medicine
Mar 29, 2021
0
439
A team of nanobiotechnologists at Harvard's Wyss Institute for Biologically Inspired Engineering and the Dana-Farber Cancer Institute (DFCI) led by Wyss Founding Core Faculty member William Shih, Ph.D., has devised a programmable ...
Bio & Medicine
Mar 22, 2021
0
149
The genome editing technology CRISPR has emerged as a powerful new tool that can change the way we treat disease. The challenge when altering the genetics of our cells, however, is how to do it safely, effectively, and specifically ...
Bio & Medicine
Mar 1, 2021
0
2254
